[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![SentinelFlash Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1873821816604565505.png) StockSentinel [@SentinelFlash](/creator/twitter/SentinelFlash) on x XX followers
Created: 2025-07-24 00:00:31 UTC

$AXSM: Axsome Therapeutics is transforming the CNS biotech landscape with rapid revenue growth and a pipeline targeting multi-billion-dollar markets. Auvelity’s uptake is fueling momentum, while Symbravo and new indications could drive a major expansion. Analysts see 46%+ revenue CAGR and a path to profitability. Is this the next breakout CNS franchise?


XXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1948171400537092166/c:line.svg)

**Related Topics**
[momentum](/topic/momentum)
[quarterly earnings](/topic/quarterly-earnings)
[$axsm](/topic/$axsm)

[Post Link](https://x.com/SentinelFlash/status/1948171400537092166)